Page last updated: 2024-09-05

lapatinib and Cruveilhier-Baumgarten Syndrome

lapatinib has been researched along with Cruveilhier-Baumgarten Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Choi, SH; Choi, SJ; Jang, JK; Jung, KH; Kang, HJ; Kim, DW; Lee, JB; Lee, SS; Park, HJ	1

Other Studies

1 other study(ies) available for lapatinib and Cruveilhier-Baumgarten Syndrome

Article	Year
Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT. Radiology, 2022, Volume: 305, Issue:3 Topics: Ado-Trastuzumab Emtansine; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deep Learning; Female; Humans; Hypertension, Portal; Lapatinib; Middle Aged; Receptor, ErbB-2; Retrospective Studies; Spleen; Splenomegaly; Tomography, X-Ray Computed	2022

Article

Year

Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT.

Radiology, 2022, Volume: 305, Issue:3

Topics: Ado-Trastuzumab Emtansine; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deep Learning; Female; Humans; Hypertension, Portal; Lapatinib; Middle Aged; Receptor, ErbB-2; Retrospective Studies; Spleen; Splenomegaly; Tomography, X-Ray Computed

2022